Sort   by:  
 Page size 
UnknownValidation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on <i>BRCA</i>-mutated patients undergoing risk-reducing salpingo-oophorectomy.
Not available
S-EPMC12037974 | biostudies-literature
UnknownEvaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Not available
S-EPMC6804908 | biostudies-literature
UnknownA Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis.
Not available
S-EPMC5979302 | biostudies-literature
UnknownPreoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer.
Not available
S-EPMC5852414 | biostudies-literature
UnknownA European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum-Sensitive Ovarian Cancer.
Not available
S-EPMC8018301 | biostudies-literature
UnknownClinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Not available
S-EPMC9553882 | biostudies-literature
UnknownUnraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.
Not available
S-EPMC11758122 | biostudies-literature
UnknownBridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
Not available
S-EPMC9575294 | biostudies-literature
UnknownErgonomics in the operating room and surgical training: a survey on the Italian scenario.
Not available
S-EPMC11337608 | biostudies-literature
UnknownAlternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.
Not available
S-EPMC9512829 | biostudies-literature
Sort   by:  
 Page size